In the first such step by a major medical center, the clinic says it has begun publicly disclosing the business relationships its staff has with drug makers.

Critics say drug firms worked to discredit a clinical trial that found that inexpensive pills for hypertension worked better than newer drugs.

Critics say drug firms worked to discredit a clinical trial that found that inexpensive pills for hypertension worked better than newer drugs.

The Federal Trade Commission rescinded guidance it issued 42 years ago that has allowed tobacco companies to make claims about tar and nicotine levels based on testing by a machine.

A new survey from Microsoft suggests that self-diagnosis by search engine frequently leads Web searchers to conclude the worst about what ails them.

The studies were issued as President-elect Barack Obama and Congressional Democrats take aim at the plans and consider cutting the payments they receive.

The health insurance industry said it would support a plan requiring insurers to accept all customers, but asked that Congress require all Americans to have coverage in return.

After a Senate inquiry found evidence of deceptive marketing, AARP has hired an outside investigator to look into sales of some of its popular health insurance products.

The court upheld the right of states to prohibit the sale of doctor-specific prescription drug data that is widely used in pharmaceutical marketing.

Neglect hurt returns from health care stocks for a while, but in a market like this, being ignored can lead to an outperformance.